Industrial hemp's market potential is hindered by a definition problem. Policy solutions aim to clarify regulations for ...

Israel's Health Ministry proposes significant changes to medical cannabis guidelines, aiming to integrate treatment into ...

Explore the Trump administration's federal medical cannabis reclassification, moving it from a highly controlled category and ...

A recent advisory from Maine's Office of Cannabis Policy highlights unsafe levels of mold and pesticides in medical cannabis ...

The US industrial hemp market faces significant policy challenges, risking its economic potential. Learn how current ...

The West Virginia Supreme Court is reviewing if medical cannabis odor alone provides probable cause for home searches, ...

A campaigner advocates for Crown Dependencies to implement cannabis policy pilot schemes, focusing on public health data and ...

Medical cannabis program enrollment is expected to surge after Schedule III rescheduling. Learn how tax relief, insurance ...

Florida regulators have cited multi-state operator Trulieve for alleged environmental violations at a cannabis cultivation ...

Explore how U.S. Congressional actions are impacting industrial hemp businesses and the proposed marijuana rescheduling, ...

The US Justice Department's Schedule III reclassification for medical cannabis products is revitalizing investor interest.

HempToday's Kehrt Reyher discusses industrial hemp policy, CBD regulation, and market development. Insights cover legislative ...